相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epidermal Fatty Acid-Binding Protein Mediates Depilatory-Induced Acute Skin Inflammation
Di Yin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)
Intestinal fatty acid binding protein is a disease biomarker in paediatric coeliac disease and Crohn's disease
Michael Logan et al.
BMC GASTROENTEROLOGY (2022)
An altered fecal microbial profiling in rosacea patients compared to matched controls
Yi-Ju Chen et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2021)
Systematic review and meta-analysis of dermatological reactions in patients with inflammatory bowel disease treated with antitumour necrosis factor therapy
Gaurav B. Nigam et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2021)
Cutibacterium acnes as an Opportunistic Pathogen: An Update of Its Virulence-Associated Factors
Constance Mayslich et al.
MICROORGANISMS (2021)
Improvement of Atopic Dermatitis by Synbiotic Baths
Matthias Noll et al.
MICROORGANISMS (2021)
Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy
Dagmar Schierova et al.
CELLS (2021)
Adipocyte Fatty Acid-Binding Protein, Cardiovascular Diseases and Mortality
Chi-Ho Lee et al.
FRONTIERS IN IMMUNOLOGY (2021)
Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease
Laila Aldars-Garcia et al.
MICROORGANISMS (2021)
Global Prevalence and Bidirectional Association Between Psoriasis and Inflammatory Bowel Disease-A Systematic Review and Meta-analysis
Farzad Alinaghi et al.
JOURNAL OF CROHNS & COLITIS (2020)
Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review
Rapat Pittayanon et al.
GASTROENTEROLOGY (2020)
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Sudabeh Alatab et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Bacterial and fungal microbiome characterization in patients with rosacea and healthy controls
R. Wang et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Skin Manifestations in Pediatric Patients Treated With a TNF-Alpha Inhibitor for Inflammatory Bowel Disease: A Retrospective Study
Maria-Laura Cossio et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2020)
Gut Microbiota and Metabolic Specificity in Ulcerative Colitis and Crohn's Disease
Jagadesan Sankarasubramanian et al.
FRONTIERS IN MEDICINE (2020)
Is Psoriasis Treatment a Risk Factor for Inflammatory Bowel Disease?
Piotr Nehring et al.
PHARMACEUTICAL MEDICINE (2020)
Effect of methotrexate treatment on the expression of epidermal-fatty acid-binding protein (E-FABP) and apolipoproteins in patients with psoriasis
Agnieszka Owczarczyk-Saczonek et al.
POSTEPY DERMATOLOGII I ALERGOLOGII (2020)
Host-microbiota interactions in inflammatory bowel disease
Roberta Caruso et al.
NATURE REVIEWS IMMUNOLOGY (2020)
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
Christian Maaser et al.
JOURNAL OF CROHNS & COLITIS (2019)
Alterations in Skin Microbiomes of Patients With Cirrhosis
Jasmohan S. Bajaj et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Crucial Role of Microbiota in Experimental Psoriasis Revealed by a Gnotobiotic Mouse Model
Zuzana Stehlikova et al.
FRONTIERS IN MICROBIOLOGY (2019)
Dysbiosis of Skin Microbiota in Psoriatic Patients: Co-occurrence of Fungal and Bacterial Communities
Zuzana Stehlikova et al.
FRONTIERS IN MICROBIOLOGY (2019)
Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasis
Anna Baran et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2019)
Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases
Barbara Ruder et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
metamicrobiomeR: an R package for analysis of microbiome relative abundance data using zero-inflated beta GAMLSS and meta-analysis across studies using random effects models
Nhan Thi Ho et al.
BMC BIOINFORMATICS (2019)
Intestinal Fatty Acid Binding Protein, a Biomarker of Intestinal Barrier, is Associated with Severity of Psoriasis
Mariusz Sikora et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response
Stepan Coufal et al.
CELLS (2019)
Oral Microbiota Composition and Antimicrobial Antibody Response in Patients with Recurrent Aphthous Stomatitis
Zuzana Stehlikova et al.
MICROORGANISMS (2019)
Dermatological Manifestations in Pediatric Patients with Inflammatory Bowel Diseases on Anti-TNF Therapy
Shilpa Sridhar et al.
INFLAMMATORY BOWEL DISEASES (2018)
TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis
Curdin Conrad et al.
NATURE COMMUNICATIONS (2018)
Microbiota Composition May Predict Anti-Tnf Alpha Response in Spondyloarthritis Patients: an Exploratory Study
Thomas Bazin et al.
SCIENTIFIC REPORTS (2018)
Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarization
Hsin-Wen Chang et al.
MICROBIOME (2018)
Association of Psoriasis With Inflammatory Bowel Disease A Systematic Review and Meta-analysis
Yun Fu et al.
JAMA DERMATOLOGY (2018)
Identification of Dietzia Species in a Patient with Endophthalmitis following Penetrating Injury with Retained Intraocular Metallic Foreign Body
Jesintha Navaratnam et al.
CASE REPORTS IN INFECTIOUS DISEASES (2018)
Fungal microbiota dysbiosis in IBD
Harry Sokol et al.
GUT (2017)
Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing
Jeff Chang et al.
GASTROENTEROLOGY (2017)
Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis
Allyson L. Byrd et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Time to clinical response and remission for therapeutics in inflammatory bowel diseases: what should the clinician expect, what should patients be told?
Abhinav Vasudevan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis
Lukas Bajer et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Matrix metalloproteinase MMP9 maintains epithelial barrier function and preserves mucosal lining in colitis associated cancer
Adani Pujada et al.
ONCOTARGET (2017)
The Critical and Multifunctional Roles of Antimicrobial Peptides in Dermatology
Toshiya Takahashi et al.
DERMATOLOGIC CLINICS (2017)
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease
Marcus Harbord et al.
JOURNAL OF CROHNS & COLITIS (2016)
Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis
Misagh Alipour et al.
JOURNAL OF CROHNS & COLITIS (2016)
Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition
Maria K. Magnusson et al.
JOURNAL OF CROHNS & COLITIS (2016)
Whole metagenome profiling reveals skin microbiome-dependent susceptibility to atopic dermatitis flare
Kern Rei Chng et al.
NATURE MICROBIOLOGY (2016)
Psoriasis and inflammatory bowel disease: links and risks
Christoforos Vlachos et al.
PSORIASIS-TARGETS AND THERAPY (2016)
Delftia acidovorans: A rare pathogen in immunocompetent and immunocompromised patients
Huseyin Bilgin et al.
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY (2015)
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study
Elisabetta Lolli et al.
JOURNAL OF CROHNS & COLITIS (2015)
Fitting Linear Mixed-Effects Models Using lme4
Douglas Bates et al.
JOURNAL OF STATISTICAL SOFTWARE (2015)
Inflammatory Bowel Disease: Etiology, Pathogenesis and Current Therapy
Joshua K. Ko et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Colonization and Infection of the Skin by S. aureus: Immune System Evasion and the Response to Cationic Antimicrobial Peptides
Sunhyo Ryu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Biogeography and individuality shape function in the human skin metagenome
Julia Oh et al.
NATURE (2014)
Role of the gut microbiota in inflammatory bowel disease pathogenesis: What have we learnt in the past 10 years?
Georgina L. Hold et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Nestin Expression is Increased in the Suprabasal Epidermal Layer in Psoriasis Vulgaris
Akira Watarai et al.
ACTA DERMATO-VENEREOLOGICA (2013)
Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease
Giammarco Mocci et al.
JOURNAL OF CROHNS & COLITIS (2013)
Correlations between Psoriasis and Inflammatory Bowel Diseases
Nevena Skroza et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis
Heidi H. Kong et al.
GENOME RESEARCH (2012)
Structure, function and diversity of the healthy human microbiome
Curtis Huttenhower et al.
NATURE (2012)
Paradoxical inflammation induced by anti-TNF agents in patients with IBD
Isabelle Cleynen et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
Human Defensins: Potential Tools for Clinical Applications
Jochen Winter et al.
POLYMERS (2012)
Skin manifestations of inflammatory bowel disease
Brian L. Huang et al.
FRONTIERS IN PHYSIOLOGY (2012)
Pseudomonas Skin Infection Clinical Features, Epidemiology, and Management
Douglas C. Wu et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2011)
Frequency and Risk Factors for Extraintestinal Manifestations in the Swiss Inflammatory Bowel Disease Cohort
Stephan R. Vavricka et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases
Helena Tlaskalova-Hogenova et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2011)
Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis
Akira Andoh et al.
JOURNAL OF GASTROENTEROLOGY (2011)
The skin microbiome
Elizabeth A. Grice et al.
NATURE REVIEWS MICROBIOLOGY (2011)
The genus Dietzia: a new home for some known and emerging opportunist pathogens
Roland J. Koerner et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2009)
Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study
H. Fidder et al.
GUT (2009)
Staphylococcus epidermidis - the 'accidental' pathogen
Michael Otto
NATURE REVIEWS MICROBIOLOGY (2009)
Topographical and Temporal Diversity of the Human Skin Microbiome
Elizabeth A. Grice et al.
SCIENCE (2009)
Bacterial Community Variation in Human Body Habitats Across Space and Time
Elizabeth K. Costello et al.
SCIENCE (2009)
Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora
Alexander Swidsinski et al.
INFLAMMATORY BOWEL DISEASES (2008)
Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases
C. D. Packey et al.
JOURNAL OF INTERNAL MEDICINE (2008)
Development of 16S rRNA-based probes for the identification of Gram-positive anaerobic cocci isolated from human clinical specimens
A. C. M. Wildeboer-Veloo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss
AR Moschen et al.
GUT (2005)
The immunological and genetic basis of inflammatory bowel disease
G Bouma et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Potential role of anaerobic cocci in impaired human wound healing
IB Wall et al.
WOUND REPAIR AND REGENERATION (2002)
分享论文
